Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-01-25

FDA Approved: CARBIDOPA, LEVODOPA AND ENTACAPONE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved Rising Pharma's original application for a generic fixed-dose combination of carbidopa, levodopa, and entacapone. This approval makes the Parkinson…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbidopa, Levodopa and Entacapone (carbidopa/levodopa/entacapone)

Snippet

ORIG AP for CARBIDOPA, LEVODOPA AND ENTACAPONE (CARBIDOPA, LEVODOPA AND ENTACAPONE)